Hijack of the ubiquitin proteasome system is a recurring theme in host-pathogen interactions. HIV-1 encodes at least three `accessory factor' proteins, Vif, Vpr, and Vpu, each known to interact with and retarget a human ubiquitin ligase with deleterious consequences for the host. The best characterized of the accessory factors is Vif, which is required for viral infectivity in T-lymphocytes. In the absence of Vif, the APOBEC3 family of restriction factors is expressed in these cells and induces lethal hypermutation of the viral genome. Vif serves as a viral countermeasure to APOBEC3 proteins by recruiting them to CUL5, a member of the CRL ubiquitin ligases, for K48-linked polyubiquitination thereby sentencing them to proteasomal degradation. Affinity purification-mass spectrometry approaches implicate a large cast of cellular proteins as Vif interactors; the work in this dissertation focuses on understanding the functional significance of a small number of them for Vif. In summary, we find the NEDD8 E2 enzyme UBE2F is critical for activation of the Vif-hijacked ubiquitin ligase, and is recruited to CUL5 by the RING-protein RBX2. The NEDD8 pathway is druggable at the E1 step, and the UBE2F pathway represents a novel drug target for relatively specific inhibition of Vif. Ligands influence the conformational state of Vif, a natively disordered protein. We find that Vif is able to simultaneously bind nucleic acids and components of the ubiquitylation machinery, resulting in a conformation with physical properties not observed in Vif complexes lacking either nucleic acid or ubiquitylation components.
Cookie SettingseScholarship uses cookies to ensure you have the best experience on our website. You can manage which cookies you want us to use.Our Privacy Statement includes more details on the cookies we use and how we protect your privacy.